sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> gastrointestinal diseases market

report

Gastrointestinal Diseases Market, by Drug Category (Antacid & Anti-Ulcerant, GIT Anti-inflammatory, Antiemetic, Anti-diarrhoea and Other GIT Therapeutics) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC115 October 2016 62 FREE 10% CUSTOMIZATION

Gastrointestinal Diseases Market is expected to grow from USD 17.27 billion in 2016 and reach USD 19.79 billion in 2022, growing at a CAGR of 2.3% during the forecast period.

Our industry experts anticipate that within the gastrointestinal diseases market, the GIT Anti-inflammatory drug will grow at the fastest CAGR ranging from 1% to .5%, during the forecast period. Based on the geographic regions, our experts anticipate that Europe will be the fastest-growing segment during the forecast period. The Europe region will grow at a CAGR ranging from 1% to 0.3% by 2022.

KEY BENEFITS OF THE REPORT

  • Thorough understanding of the dynamics influencing the various segments of this market
  • Detailed analysis of the regulatory environment impacting the growth of this market
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The gastrointestinal diseases market is driven by the continuous rise in the incidences of the gastrointestinal diseases worldwide.
  • According to the Gastroenterological Society of Australia, the gastrointestinal diseases such as Crohn’s disease, ulcerative colitis, and inflammatory bowel diseases are increasing in Australia and other countries at a constant rate. Thus, increasing the demand for the gastrointestinal diseases therapeutics, leading to the market growth to great extent.
  • Furthermore, the rising interest of the companies in increasing the investments in the gastrointestinal diseases market will drive the market growth to some extent.
  • Additionally, it is also noticed that the demand or sale of the gastrointestinal drugs is increased in the developing and developed regions, which will act as a potential driver for the market growth.
  • However, development of new alternative therapies to treat the gastrointestinal diseases, coupled with the regulatory restraints to develop the gastrointestinal drugs will hamper the overall market growth.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s gastrointestinal diseases market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the gastrointestinal diseases market by the following segments:

  • Gastrointestinal Diseases Market, by Drug Category
    • Antacid & Anti-Ulcerant
    • GIT Anti-inflammatory
    • Antiemetic
    • Anti-diarrhoea
    • Other GIT Therapeutics 

KEY MARKET PLAYERS

Key players in the gastrointestinal diseases market include:

  • AstraZeneca
  • Valeant (Salix Pharmaceuticals)
  • Takeda Pharmaceutical Company Limited
  • Shire
  • Johnson & Johnson Private Limited
  • Eisai Co., Ltd.
  • Allergan

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

Gastrointestinal Diseases Market

TRENDING RELATED REPORT

Dermatology Devices Market, by Diagnostic Devices (Dermatoscopes, Microscopes, Imaging Techniques), Treatment Devices (Liposuction, Microdermabrasion, Cryotherapy, Electrosurgical, Light Therapy Devices, Lasers), Applications (Cancer Diagnosis, Wrinkle Removal, Skin Rejuvenation, Skin Resurfacing, Vascular Lesions, Acne, Psoriasis, Hair Removal) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definition
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Major Selling Drug Analysis
    2. Pipeline Analysis
    3. Key Event Analysis
  5. GASTROINTESTINAL DISEASES MARKET, BY DRUG CATEGORY
    1. Segment Share
    2. Drug Category
      1. Antacid & Anti-Ulcerant
      2. GIT Anti-inflammatory
      3. Antiemetic
      4. Anti-diarrhoea
      5. Other GIT Therapeutics
  6. GASTROINTESTINAL DISEASES MARKET, BY GEOGRAPHY
    1. North America
      1. By Country
        1. U.S.
        2. Canada
      2. By Drug Category
    2. Europe
      1. By Country
        1. France
        2. Germany
        3. Rest of Europe
      2. By Drug Category
    3. Asia-Pacific
      1. By Country
        1. India
        2. China
        3. Rest of Asia-Pacific
      2. By Drug Category
    4. Rest of the World (ROW)
      1. Latin America
      2. The Middle East & Africa
        1. By Drug Category
  7. COMPETITIVE LANDSCAPE
    1. Market Share Analysis
    2. Key Innovator Companies
  8. KEY MARKET PLAYERS
    1. AstraZeneca
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. Valeant (Salix Pharmaceuticals)
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Takeda Pharmaceutical Company Limited
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Shire
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Johnson & Johnson Private Limited
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Eisai Co., Ltd.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Allergan
      1. Overview
      2. Key Strategies
      3. Recent Developments
  9. SCALAR 360 DEGREE MARKET PERSPECTIVE
  10. APPENDIX

 

LIST OF TABLES

Table 1.                Definitions

Table 2.                Market Summary: Global Gastrointestinal Diseases Market

Table 3.                Global Gastrointestinal Diseases Market Drivers

Table 4.                Global Gastrointestinal Diseases Market Restraints

Table 5.                Global Gastrointestinal Diseases Market Size (US$ million), Major Selling Drug Analysis (2015)

Table 6.                Global Gastrointestinal Diseases Market Size (US$ million), Pipeline Drug Analysis (2014 – 2022)

Table 7.                Key event analysis- Global Gastrointestinal Diseases Market

Table 8.                Global Gastrointestinal Diseases Market Size with Pipeline Drug Revenue (US$ million), By Drug Category (2014 – 2022)

Table 9.                Global Gastrointestinal Diseases Market Size (US$ million), By Drug Category (2014 – 2022)

Table 10.              Global Antacid & Anti-Ulcerant Market Size (US$ million), By Region (2014 – 2022)

Table 11.              Global GIT Anti-inflammatory Market Size (US$ million), By Region (2014 – 2022)              

Table 12.              Global Antiemetic Market Size (US$ million), By Region (2014 – 2022)

Table 13.              Global Anti-diarrhoea Market Size (US$ million), By Region (2014 – 2022)

Table 14.              Global Other GIT Therapeutics Market Size (US$ million), By Region (2014 – 2022)

Table 15.              Global Gastrointestinal Diseases Market Size (US$ million), By Geography (2014 – 2022)

Table 16.              North America Gastrointestinal Diseases Market Size (US$ million), By Country (2014 – 2022)

Table 17.              Gastrointestinal Diseases Market in U.S., Market Size (US$ million) and Y-o-Y Growth (%)

Table 18.              Gastrointestinal Diseases Market in Rest of Canada, Market Size (US$ million) and Y-o-Y Growth (%)

Table 19.              North America Gastrointestinal Diseases Market Size (US$ million), By Drug Category (2014 – 2022)

Table 20.              Europe Gastrointestinal Diseases Market Size (US$ million), By Country (2014 – 2022)

Table 21.              Gastrointestinal Diseases Market in Germany, Market Size (US$ million) and Y-o-Y Growth (%)

Table 22.              Gastrointestinal Diseases Market in France, Market Size (US$ million) and Y-o-Y Growth (%)

Table 23.              Gastrointestinal Diseases Market in Rest of the Europe, Market Size (US$ million) and Y-o-Y Growth (%)

Table 24.              Europe Gastrointestinal Diseases Market Size (US$ million), By Drug Category (2014 – 2022)

 

LIST OF FIGURES

 

Figure 1.               Research Methodology

Figure 2.               Gastrointestinal Diseases Market, By Drug Category

Figure 3.               Gastrointestinal Diseases Market, By Geography             

Figure 4.               Global Gastrointestinal Diseases Market Size (US$ million), By Drug Category (2016 vs. 2022)

Figure 5.               Global Gastrointestinal Diseases Market Size (US$ million), By Geography (2016 vs. 2021)

Figure 6.               Global Gastrointestinal Diseases Market Share (%), By Drug Category, 2016 & 2022

Figure 7.               Global Gastrointestinal Diseases Market Size (US$ million), By Drug Category, 2016 & 2022

Figure 8.               Global Gastrointestinal Diseases Market Share (%), By Geography, 2016 & 2021

Figure 9.               Global Gastrointestinal Diseases Market Size (US$ million), By Geography, 2016 & 2022

Figure 10.            North America Gastrointestinal Diseases Market Share (%), By Country, 2016 & 2021

Figure 11.            North America Gastrointestinal Diseases Market Size (US$ million), By Country, 2016 & 2021

Figure 12.            Europe Gastrointestinal Diseases Market Share (%), By Country, 2016 & 2022

Figure 13.            Europe Gastrointestinal Diseases Market Size (US$ million), By Country, 2016 & 2022

Figure 14.            Asia-Pacific Gastrointestinal Diseases Market Share (%), By Country, 2016 & 2022

Figure 15.            Asia-Pacific Gastrointestinal Diseases Market Size (US$ million), By Country, 2016 & 2022

Figure 16.            Rest of the World Gastrointestinal Diseases Market Share (%), By Country, 2016 & 2021

Figure 17.            Rest of the World Gastrointestinal Diseases Market Size (US$ million), By Country, (2016 & 2021)

Figure 18.            Market Share Analysis of Key Players

Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us